-
In this cross-sectional population based study from California, it is apparent that screening is currently applied to older women without consideration of health status.
-
Seizures should be a red flag to consider treatment to modify stroke risk.
-
The FDA has approved another rapid-acting insulin to cover mealtime blood sugar spikes.
-
-
Annual, or less frequent, surveillance intervals are effective for aneurysms < 45 mm in diameter.
-
In a prospective, randomized trial, primary excision of colorectal carcinomas by laparoscopic surgery was compared with laparotomy.
-
The benefit of ICD therapy, compared to amiodarone therapy in patients with life-threatening arrhythmia, continues to increase over time, and long-term data support the use of an ICD as first line therapy for secondary prevention of sudden cardiac death.
-
Although PPIs are considered to be among the safest of drugs, these studies suggest that PPIs increase the risk for hospitalized patients to develop C. difficile-related diarrhea.
-
The National Cholesterol Education Program (NCEP), a product of a collaboration of the National Heart, Lung, and Blood Institutes, the American College of Cardiology, and the American Heart Association, has updated its clinical practice guideline on cholesterol management.
-
FDA has approved a 5-nitroimidazole for the treatment of trichomoniasis, giardiasis, and amebiasis. Tinidazole, a second-generation nitroimidazole antiprotozoal agent, is marketed as TindamaxTM by Presutti Laboratories.